Back to results
Not yet recruiting

Neutrophil Biomarker Test for Predicting Clinical Benefit From Immunotherapy Based on Flow Cytometry Analysis

NCT07246759

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Heidelberg University Hospital

Heidelberg, Germany

+2 additional locations

Contact

Michal Harel VP of Translational Medicine, PhD

97248537558Michal@oncohost.com
View on ClinicalTrials.gov
Neutrophil Biomarker Test for Predicting Clinical Benefit From Immunotherapy Based on Flow Cytometry Analysis — TrialFind